Clinical trial
Exisulind in Preventing Polyps in Patients With Familial Adenomatous Polyposis
NCT00026468 · University of Utah, Other · Withdrawn
Key facts
| NCT number | NCT00026468 |
|---|---|
| Title | Exisulind in Preventing Polyps in Patients With Familial Adenomatous Polyposis |
| Official title | Chemoprevention of Duodenal Polyps in Familial Adenomatous Polyposis |
| Lead sponsor | University of Utah, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Withdrawn |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Colorectal Cancer, Small Intestine Cancer |
| Intervention type | Drug |
| Interventions | exisulind |
| Enrollment | 0 |
| Start date | Jul 1, 1999 |
| Primary completion | Jul 1, 1999 |
| Completion | Jul 1, 1999 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 24, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: